The Federal Trade Commission has finalized an order against IntelliVision Technologies Corp for making unsubstantiated claims regarding the accuracy and effectiveness of its AI-powered facial recognition software, highlighting the increasing regulatory scrutiny on AI technologies and the necessity for transparency and accountability.
The integration of AI in healthcare raises significant legal issues related to liability, algorithm biases, and cybersecurity, necessitating compliance with evolving regulations from bodies like the FDA, MHRA, and EU, while highlighting the importance of human oversight in decision-making processes.
The United States Patent and Trademark Office is revising its audit procedures for trademark maintenance filings to address the rise of potentially fraudulent digitally generated specimens, particularly from online “specimen farms” and generative AI platforms, ensuring the integrity of the trademark register.
The deployment of AI systems in manufacturing to improve worker safety raises important legal considerations regarding compliance with collective bargaining agreements, data collection protocols, and potential impacts on OSHA inspections.
In 2025, significant shifts in AI regulation are expected, with a decrease in federal oversight and increased state-level legislation, particularly in California and New York, addressing workplace AI use, while companies will need to adopt governance frameworks to navigate a complex legal landscape influenced by both domestic and international standards.
The document outlines a comprehensive framework for obtaining informed consent in AI systems, emphasizing transparency, accountability, and compliance with evolving data protection regulations such as GDPR and the California Consumer Privacy Act.
